ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

First Chop Awards Made, 17 Others In Negotiation For NCI Program To Upgrade Community Cancer Care

October 24, 1980

Blood Vessel Growth Inhibitor May Be Tested Against KS

August 16, 1991

NiH Conference: More Discord Than Consensus At Statement’s Presentation

January 31, 1997

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

Radiation, Tamoxifen After Surgery Reduce Breast Cancer Occurrence

March 25, 2011

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002